Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aflibercept as Adjunctive Treatment for Filtration Surgery in Neovascular

NCT04970251 is registered in ClinicalTrials.gov with Siriraj Hospital as lead sponsor.

NCT NCT04970251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04970251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aflibercept as Adjunctive Treatment for Filtration Surgery in Neovascular
Lead sponsor
Siriraj Hospital
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2018
Completion date
March 31, 2021
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma secondary to eye inflammation, intraocular pressure, neovascular glaucoma, vascular endothelial growth factor overexpression